Summary AimThe aim of this study was to find predictive factors of 1-year visual outcome, analyzing novel optical coherence tomography (OCT) biomarkers in exsudative age-related macular degeneration (choroidal neovascularization (CNV)) in two groups of different treatment modalities. MethodsIn all, 34 consecutive patients with new-onset CNV were randomized 1:1 to receive either ranibizumab monotherapy or ranibizumab combined with photodynamic therapy (PDT) with verteporfin. After three initial injections with ranibizumab, re-treatment was performed according to an as-needed scheme; PDT was performed once at baseline. Best-corrected visual acuity (BCVA) and OCT parameters like central macular volume (CMV), central macular thickness (or central retinal thickness (CRT)), subretinal and intraretinal fluid, fibrovascular lesion thickness, or inner segment/outer segment (IS/OS) junction were analyzed. ResultsAfter 12 months, a visual gain of 6.1 letters was found in the monotherapy group, whereas patients in the combination therapy group lost − 4.8 letters from baseline to the 12-month visit. CMV and CRT decreased considerably between baseline and month 2–3 in both groups, with a following slight increase until month 12. Additional application of PDT had negative effect to 12-month BCVA, whereas higher baseline BCVA and integrity of the IS/OS junction at month 12 had positive effect to 12-month BCVA. ConclusionsBetter baseline BCVA and the integrity of IS/OS junction at 12-month visit were the most important predictive factors for final BCVA. Combination therapy caused worse final BCVA and a higher degree of IS/OS disruption.
ranibizumab         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ranibizumab           

macular                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macula_of_retina      

OS                            0.9999941994751654^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Operating_system      

age-related macular degeneration1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_degeneration  

IS                            0.9331437097261449^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/International_System_of_Units

PDT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Photodynamic_therapy  

choroidal neovascularization  0.9985575417509117^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Choroidal_neovascularization

CRT                           0.9999531945415271^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cathode_ray_tube      

CNV                           0.9999999998706244^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Copy-number_variation 

macular                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macula_of_retina      

predictive factors            0.9999999999943157^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Predictive_factor     

photodynamic therapy          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Photodynamic_therapy  

OS                            0.9999941994751654^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Operating_system      

optical coherence tomography (OCT)1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Optical_coherence_tomography

monotherapy                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Combination_therapy   

OS                            0.9999941994751654^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Operating_system      

Combination therapy           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Combination_therapy   

fluid                         0.8564224810117979^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Fluid                 

verteporfin                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Verteporfin           

CMV                           0.9999999990188826^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cytomegalovirus       

ranibizumab                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ranibizumab           

visual acuity                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Visual_acuity         

CRT                           0.9999531945415271^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cathode_ray_tube      

IS                            0.9331437097261449^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/International_System_of_Units

CMV                           0.9999999990188826^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cytomegalovirus       

retinal                       0.9999999999986358^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Retina                

predictive factors            0.9999999999943157^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Predictive_factor     

IS                            0.9331437097261449^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/International_System_of_Units

OS                            0.9999941994751654^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Operating_system      

lesion                        0.9999999999920419^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Lesion                

biomarkers                    0.9999999999506599^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Biomarker             

PDT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Photodynamic_therapy  

combination therapy           0.9999999999006377^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Combination_therapy   

CNV                           0.9999999998706244^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Copy-number_variation 

monotherapy                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Combination_therapy   

PDT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Photodynamic_therapy  

OCT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Optical_coherence_tomography

IS                            0.9331437097261449^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/International_System_of_Units

ranibizumab                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ranibizumab           

